U.S. approves conditional use of avian influenza vaccine amid spreading outbreak U.S. greenlights temporary use of bird flu ...
Moderna is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at what to expect in ...
With so much H5N1 circulating in the U.S., scientists worry we are a few mutations away from a potential human pandemic.
Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily change as influenza can rapidly change.
As bird flu cases continue to pop up in humans, Canada announced Wednesday that it purchased 500,000 doses of vaccine ...
In 2023, Moderna commenced a Phase 1/2 study to generate safety and immunogenicity data for an investigational pandemic influenza vaccine (mRNA-1018) candidate against the H5 and H7 avian ...
A second federal judge paused Trump's order against gender-affirming care for youth. ( AP) Johnson & Johnson aims to have a ...
“Avian flu variants have proven to be particularly ... ensure that Americans have the tools they need to stay safe.” A Moderna spokesperson told MassLive the company is preparing to advance ...
Moderna's vaccine is designed to target H5 and H7 avian influenza viruses. The company plans to move into phase 3 clinical trials to test the vaccine in a larger group of people after receiving ...
Bird flu has now spread to humans in a dozen states after public health officials confirmed an Ohio man had contracted the ...
Zoetis said the U.S. Department of Agriculture's Center for Veterinary Biologics issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is ...